Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SELLAS Life Sciences Group, Inc. | CFO | Common Stock | 105K | $118K | $1.13 | Dec 4, 2024 | Direct |
SELLAS Life Sciences Group, Inc. | CFO | Class A Common Stock | 54.9K | $59.3K | $1.08 | Dec 6, 2023 | Direct |
SELLAS Life Sciences Group, Inc. | CFO | Stock Option (Right to Buy) | 75K | Jan 22, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SLS | SELLAS Life Sciences Group, Inc. | Dec 4, 2024 | 1 | -$8.1K | 4 | Dec 5, 2024 | CFO |
SLS | SELLAS Life Sciences Group, Inc. | Jan 22, 2024 | 2 | $0 | 4 | Jan 25, 2024 | CFO |
SLS | SELLAS Life Sciences Group, Inc. | Dec 6, 2023 | 1 | -$3.16K | 4 | Dec 8, 2023 | CFO |
SLS | SELLAS Life Sciences Group, Inc. | Feb 2, 2023 | 2 | $0 | 4 | Feb 3, 2023 | CFO |
SLS | SELLAS Life Sciences Group, Inc. | Dec 5, 2022 | 1 | -$3K | 4 | Dec 5, 2022 | Senior VP, Finance & CAO |
SLS | SELLAS Life Sciences Group, Inc. | Jan 31, 2022 | 2 | $0 | 4 | Feb 1, 2022 | Senior VP, Finance & CAO |
SLS | SELLAS Life Sciences Group, Inc. | Dec 2, 2021 | 1 | -$1.45K | 4 | Dec 3, 2021 | VP, Finance & Corp Controller |
SLS | SELLAS Life Sciences Group, Inc. | Mar 4, 2021 | 0 | $0 | 4/A | Dec 3, 2021 | VP, Finance & Corp Controller |